Clinical Trial Update: Sofia RSV FIA Field Study

View source ↗

Summary

Quidel's Sofia RSV FIA field study for respiratory syncytial virus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Sofia RSV FIA

Snippet

Sponsor: Quidel Corporation | Conditions: Respiratory Syncytial Virus | Status: COMPLETED